Overview

A Phase 1b/2 Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Status:
Not yet recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Xentria, Inc.